Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring the importance of a thorough evaluation.

Attendees of the AAO 2025 annual meeting will have a chance to preview the virtual technician training platform on October 19 ...

Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...

The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...

BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for multifocal vision correction. The lens features a diffractive optic design and ...

Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...

The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...

REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...

The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...

The jump from training to independent practice is a uniquely personal experience. For some, it feels like a natural next step ...

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing ...